D. E. Shaw & Co., Inc. Pfizer Inc Put Options Transaction History

D. E. Shaw & Co., Inc.

$114 Billion
Q1 2024

Put Options

27 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $88.2 Million - $101 Million	3,407,500 Added 38.29%	12,307,600 $342 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $109 Million - $141 Million	4,165,300 Added 87.97%	8,900,100 $256 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $70.4 Million - $82.3 Million	2,193,700 Added 86.33%	4,734,800 $157 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $23.3 Million - $27 Million	645,100 Added 34.02%	2,541,100 $93.2 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $43.7 Million - $56.9 Million	1,109,200 Added 140.98%	1,896,000 $77.4 Million

Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $11.9 Million - $15.6 Million	-285,800 Reduced 26.65%	786,800 $40.3 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $8.62 Million - $10.5 Million	196,900 Added 22.48%	1,072,600 $46.9 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $54.4 Million - $64.5 Million	-1,168,300 Reduced 57.16%	875,700 $45.9 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $3.29 Million - $4.08 Million	-71,900 Reduced 3.4%	2,044,000 $106 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $2.48 Million - $3.68 Million	-60,000 Reduced 2.76%	2,115,900 $125 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $17 Million - $21.8 Million	-432,800 Reduced 16.59%	2,175,900 $93.6 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $58.1 Million - $65.9 Million	-1,619,100 Reduced 38.3%	2,608,700 $102 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $45.1 Million - $50.9 Million	1,347,000 Added 46.76%	4,227,800 $153 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $22.5 Million - $28.7 Million	673,200 Added 30.49%	2,880,800 $106 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $37.7 Million - $44.2 Million	1,187,800 Added 116.47%	2,207,600 $81 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $11.1 Million - $13.4 Million	-367,400 Reduced 26.49%	1,019,800 $33.3 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $7.03 Million - $10 Million	259,900 Added 23.06%	1,387,200 $45.3 Million
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $18.2 Million - $20.7 Million	-553,400 Reduced 32.93%	1,127,300 $44.2 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $51.7 Million - $67 Million	1,590,700 Added 1767.44%	1,680,700 $60.4 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $2.77 Million - $3.11 Million	75,000 Added 500.0%	90,000 $3.9 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $1.25 Million - $1.38 Million	-33,400 Reduced 69.01%	15,000 $637,000
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $611,673 - $697,374	-15,900 Reduced 24.73%	48,400 $2.11 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $5.9 Million - $7.16 Million	-171,300 Reduced 72.71%	64,300 $2.83 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $7.28 Million - $7.76 Million	220,600 Added 1470.67%	235,600 $8.55 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $20.7 Million - $24 Million	-647,400 Reduced 97.74%	15,000 $532,000
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $921,302 - $977,533	-27,700 Reduced 4.01%	662,400 $24 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $21.4 Million - $23.6 Million	690,100	690,100 $24.6 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

Vanguard Group Inc Valley Forge, PA

507M
Shares

$14.2 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

431M
Shares

$12.1 Billion
0.28% of portfolio
State Street Corp Boston, MA

291M
Shares

$8.13 Billion
0.37% of portfolio
Wellington Management Group LLP Boston, MA

178M
Shares

$4.97 Billion
0.89% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

122M
Shares

$3.42 Billion
0.79% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account